“Room for improvement” in care after breast cancer

	Tweet

Survivors of early-stage breast cancer generally receive good health care in the first year after they finish treatment, but not all of them get the recommended check-up mammogram, according to a new report.

Among every 100,000 women alive today in the United States, 815 are breast cancer survivors. Monitoring after treatment is important for detection of a second cancer, reassurance that the cancer remains in remission, and identification of side effects from the cancer treatment.

Dr. Jeanne S. Mandelblatt of the Lombardi Comprehensive Cancer Center in Washington, DC, and her colleagues studied a group of survivors with stage I or II breast cancer who had received primary treatment. The patients were asked to complete calendar diaries detailing health care use for one year after treatment.

Of the 558 women recruited, 391 provided a health care diary. The researchers found that, on average, these survivors used health service 30 times in the year after treatment, a rate higher than that of the general population. The total annual costs of care averaged more than $1,800 per patient, with medical office visits being the major component of costs.

While there were geographic variations in initial treatment patterns and in post-treatment costs, the team found that higher use, and cost, of care was predicted by the type of cancer treatment, the presence of depression, and the overall physical function of the patients, as well as the presence of other illness.

Although all women should have a mammography in the first year after treatment, the researchers report that only 62 percent did so. Women who had a lumpectomy were more likely to receive a mammogram than those who had a mastectomy, and white women were more likely to receive one than nonwhite women.

According to the authors, the use of health care resources is high in the year after diagnosis and treatment, and there is “room for improvement in the recommended use of surveillance mammography.”

They conclude that “future research should focus on ensuring that breast cancer survivors obtain recommended post-treatment surveillance and management of post-treatment symptoms that may contribute to excess (health care) use.”

SOURCE: Journal of Clinical Oncology, January 2006.

RELATED STORIES:
Just a few drinks a week tied to breast cancer   Decreased Survival for Puerto Rican Women with “Triple-Negative” Breast Cancer Subtype   AACR to Honor Leading Researchers at Breast Cancer Symposium   Fruits And Veggies Don’t Prevent Breast Cancer Recurrence   Millions of Cameroon girls suffer “breast ironing”   Peptide Delivers One-Two Punch to Breast Cancer in Pre-Clinical Study   Study confirms link between breast implants and rare form of cancer   Study examines risk factors for cancer in unaffected breast of breast cancer patients   Hair straightening chemicals not linked to breast cancer risk in African-Americans   Study Links African Ancestry to High-Risk Breast Cancer   Women often opt to surgically remove their breasts, ovaries to reduce cancer risk   New Test May Predict Breast Cancer Metastasis   Scientists Break Genetic Code for Estrogen-Positive Breast Cancer   Cell of Origin Identified for Common Type of Breast Cancer   Urine test may tell of breast cancer’s spread   Drug Could Effectively Treat, Prevent the Spread of Breast Cancer   Scientists find new drug target in breast cancer   DCIS patients who get invasive breast cancer have higher mortality   Risk of Death From Breast Cancer Higher Among Older Patients   Avastin helps breast cancer patients: study   No Sure Answers to Reduce Mammography Discomfort   Women advised to avoid ZEN bust-enhancing supplements because of possible cancer risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]